Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

FDA approves new formulation of Tracleer for pediatric PAH

Sep. 7, 2017

Phase III results presented for anacetrapib in patients with atherosclerotic vascular disease

Sep. 7, 2017

Increased SIRT4 expression linked to accelerated heart failure development

Sep. 5, 2017

High mobility group protein B1 inhibitors disclosed by Kyungpook National University

Sep. 4, 2017

FDA issues refusal to file letter for SteadyMed's Trevyent NDA

Sep. 1, 2017

University of California, Oakland divulges new vectors encoding LAMP-2 isoforms

Aug. 31, 2017

AP-14145 shows selective SK channel targeting

Aug. 31, 2017

Treating angina with ivabradine/metoprolol FDC shows promise

Aug. 31, 2017

BioCryst Pharmaceuticals divulges complement factor D inhibitors

Aug. 29, 2017

FDA grants priority review to LJPC-501 NDA

Aug. 29, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...